These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 8386213
1. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. Calogero AE, Bagdy G, Moncada ML, D'Agata R. J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213 [Abstract] [Full Text] [Related]
2. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP. Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670 [Abstract] [Full Text] [Related]
3. Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action. Bagdy G, Calogero AE, Szemeredi K, Gomez MT, Murphy DL, Chrousos GP, Gold PW. Brain Res; 1990 Dec 24; 537(1-2):227-32. PubMed ID: 2150776 [Abstract] [Full Text] [Related]
4. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. Bagdy G, Sved AF, Murphy DL, Szemeredi K. Eur J Pharmacol; 1992 Jan 21; 210(3):285-9. PubMed ID: 1535317 [Abstract] [Full Text] [Related]
5. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats. Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y. Biol Pharm Bull; 2007 Jan 21; 30(1):117-20. PubMed ID: 17202670 [Abstract] [Full Text] [Related]
8. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype. Maura G, Barzizza A, Folghera S, Raiteri M. Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar 21; 343(3):229-36. PubMed ID: 1830929 [Abstract] [Full Text] [Related]
12. Hypothalamic-pituitary-adrenal responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol. Hofmann CE, Ellis L, Yu WK, Weinberg J. Alcohol Clin Exp Res; 2007 Feb 21; 31(2):345-55. PubMed ID: 17250628 [Abstract] [Full Text] [Related]
13. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats. Anderson IK, Martin GR, Ramage AG. Br J Pharmacol; 1992 Dec 21; 107(4):1020-8. PubMed ID: 1467825 [Abstract] [Full Text] [Related]
15. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Vicentic A, Li Q, Battaglia G, Van de Kar LD. Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368 [Abstract] [Full Text] [Related]